Fundraising Fox
Autonomix Medical
NASDAQ: AMIXThe Woodlands, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Autonomix Medical
Sign up to see every warm intro you have to Autonomix Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Autonomix Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure. Its initial focus is interventional chronic pain management for pancreatic and other visceral cancer patients, with planned expansion across cardiology, pain management, pulmonology, and gastroenterology.
Founders & leadership
Autonomix Medical was founded in 2014 by David Robins, Robert Schwartz, and Landy Toth.
Board
Investors · 1
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 4 rounds · 2014–2023
▶$2.4MraisedJun 2023 · 27 investors · Other Health CareRule 506(b)
- Jonathan FosterDirector
- David RobinsDirector
- Matthew LourieExecutive Officer
- Walter KlempDirector
- Robert SchwartzExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.4M
- Minimum investment
- $10K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$675KraisedMar 2023 · 5 investors · Other Health CareRule 506(b)
- Robert SchwartzExecutive Officer
- Jonathan FosterDirector
- David RobinsDirector
- Walter KlempDirector
- Matthew LourieExecutive Officer
- Offering amount
- $675K
- Amount sold
- $675K
- Minimum investment
- $25K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2022 · 33 investors · Other Health CareRule 506(b)
- Walter KlempDirector
- Jonathan FosterDirector
- David RobinsDirector
- Robert SchwartzExecutive Officer
- Matt LourieExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $20K
- Finders' fees
- $92K
- Placement agents
- Falcon Capital Partners Limited
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedSep 2014 · 4 investors · Other Health CareRule 506(b)
- Robert Van TasselExecutive Officer
- Robert SchwartzExecutive Officer, Director
- Renee MasiDirector
- David RobinsExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Autonomix Medical do?
- Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure. Its initial focus is interventional chronic pain management for pancreatic and other visceral cancer patients, with planned expansion across cardiology, pain management, pulmonology, and gastroenterology.
- Who founded Autonomix Medical?
- Autonomix Medical was founded by David Robins, Robert Schwartz, Landy Toth in 2014.
- Who are Autonomix Medical's investors?
- Autonomix Medical's investors include BioStar Ventures.
- How much funding has Autonomix Medical raised?
- Autonomix Medical has disclosed $8.9M raised across 4 rounds.
- Where is Autonomix Medical headquartered?
- Autonomix Medical is headquartered in The Woodlands, US.